Loomis, Sayles & Company’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-460,344
Closed -$19.1M 1045
2023
Q2
$19.1M Sell
460,344
-334,795
-42% -$13.7M 0.03% 258
2023
Q1
$32.8M Buy
795,139
+6,553
+0.8% +$280K 0.06% 165
2022
Q4
$32.5M Sell
788,586
-18,861
-2% -$764K 0.07% 155
2022
Q3
$35.4M Sell
807,447
-9,770
-1% -$474K 0.07% 139
2022
Q2
$40.2M Buy
817,217
+57,902
+8% +$3.11M 0.07% 127
2022
Q1
$43.1M Sell
759,315
-14,486
-2% -$769K 0.06% 154
2021
Q4
$40.6M Sell
773,801
-20,868
-3% -$1.13M 0.05% 194
2021
Q3
$47.6M Sell
794,669
-12,329
-2% -$760K 0.06% 157
2021
Q2
$54.7M Sell
806,998
-16,390
-2% -$1.12M 0.07% 129
2021
Q1
$54M Buy
823,388
+73,660
+10% +$4.42M 0.07% 125
2020
Q4
$42.2M Buy
749,728
+325,234
+77% +$16M 0.06% 153
2020
Q3
$20.6M Buy
424,494
+8,027
+2% +$433K 0.03% 229
2020
Q2
$23.2M Buy
416,467
+36,111
+9% +$2.09M 0.04% 196
2020
Q1
$19.3M Buy
+380,356
New +$25.5M 0.04% 171
2018
Q4
Sell
-158
Closed -$11K 963
2018
Q3
$11K Sell
158
-22
-12% -$1.4K ﹤0.01% 799
2018
Q2
$9K Sell
180
-557
-76% -$29.2K ﹤0.01% 816
2018
Q1
$38K Buy
+737
New +$37.4K ﹤0.01% 633
2017
Q4
Sell
-32
Closed -$2K 967
2017
Q3
$2K Sell
32
-95
-75% -$6.29K ﹤0.01% 891
2017
Q2
$10K Hold
127
﹤0.01% 800
2017
Q1
$9K Hold
127
﹤0.01% 819
2016
Q4
$9K Buy
+127
New +$8.19K ﹤0.01% 848
2015
Q2
Sell
-8,776
Closed -$404K 951
2015
Q1
$404K Buy
+8,776
New +$408K ﹤0.01% 652

Other funds holding NUVA

Loomis, Sayles & Company's NUVA Position: Q3 2023 in Review

Loomis, Sayles & Company sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 460,344 shares — an estimated $19.1M sold.

Loomis, Sayles & Company first reported a position in NUVA in Q1 2015 and held it in 22 quarters. The position peaked at $54.7M in Q2 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Loomis, Sayles & Company reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 460,344 NuVasive, Inc. shares in Q3 2023, an estimated $19.1M.
  • Loomis, Sayles & Company first reported a position in NuVasive, Inc. in Q1 2015 and held it in 22 quarters.
  • Loomis, Sayles & Company's NuVasive, Inc. position peaked at $54.7M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.